Skip to content
Faq6 min readStandard

How Much Does Ketamine Therapy Cost?

A comprehensive breakdown of ketamine therapy costs by treatment type — IV infusion, Spravato, compounded formulations, and at-home options — plus factors that affect price.

How Much Does Ketamine Therapy Cost? - how much does ketamine cost

The Short Answer

Ketamine therapy costs vary widely depending on the type of treatment, the clinical setting, geographic location, and whether insurance coverage applies. As a general range, patients can expect to pay anywhere from $100 per month for compounded at-home formulations to $800 or more per session for in-clinic IV infusions. Understanding the full cost landscape is essential for making informed treatment decisions.

Cost Breakdown by Treatment Type

IV Ketamine Infusion

Intravenous ketamine infusion is the most studied route for psychiatric conditions but is typically not covered by insurance for off-label psychiatric use. Cost factors include the clinical setting, geographic region, and whether additional services (psychotherapy, monitoring) are bundled.

Typical cost range:

  • Per session: $400-$800
  • Initial series (6 infusions): $2,400-$4,800
  • Maintenance infusions: $400-$800 per session, typically every 2-6 weeks
  • Annual estimated cost: $4,000-$12,000+ depending on maintenance frequency

Some clinics offer package pricing for the initial series, which may reduce the per-session cost. Premium clinics in major metropolitan areas may charge more, while clinics in smaller markets or those with higher patient volume may offer lower rates.

Esketamine (Spravato)

Spravato has a high list price but is more likely to be covered by insurance due to its FDA-approved status.

Cost considerations:

  • List price per session: Approximately $600-$900
  • With insurance: Often $0-$200 per session after deductible and with prior authorization
  • Without insurance: The full list price applies, though Janssen offers a patient savings program that may reduce costs for eligible patients
  • Annual estimated cost with insurance: $2,000-$6,000 depending on copays and session frequency
  • Annual estimated cost without insurance: $15,000-$30,000+

The REMS requirement that Spravato be administered in a certified healthcare setting means that facility fees may be charged in addition to the medication cost. These facility fees, which cover the two-hour monitoring period and clinical staff time, can range from $50 to $300 per session.

Compounded Sublingual (Troches/Lozenges)

Compounded ketamine formulations prescribed for at-home use are generally the most affordable option, though they require ongoing clinical oversight.

Typical cost range:

  • Medication cost: $50-$150 per month, depending on dose and pharmacy
  • Initial consultation: $150-$400 (in-person or telehealth)
  • Follow-up appointments: $75-$250 per visit, typically monthly or bimonthly
  • Annual estimated cost: $1,500-$4,000 including consultations and medication

Several telehealth companies offer subscription-based models that bundle the consultation, prescription, and medication into a monthly fee, typically ranging from $200 to $500 per month.

Intramuscular (IM) Injection

IM ketamine sessions are priced similarly to IV infusions, though some clinics charge slightly less due to the reduced equipment and time requirements.

Typical cost range:

  • Per session: $350-$700
  • Initial series: $2,100-$4,200
  • Annual estimated cost: $3,500-$10,000+ depending on maintenance schedule

Factors That Influence Cost

Geographic Location

Ketamine therapy costs vary significantly by region. Clinics in major metropolitan areas (New York, Los Angeles, San Francisco, Miami) tend to charge at the higher end of the range, while clinics in smaller cities and rural areas may be more affordable. The density of competing providers in a given market also influences pricing.

Clinical Setting and Services

The level of clinical service provided affects cost. Some clinics offer a purely medical infusion experience, while others integrate psychotherapy, provide spa-like amenities, or include extensive pre- and post-treatment support. Ketamine-assisted psychotherapy (KAP) sessions, which involve a therapist present during the ketamine experience, are typically more expensive than standard infusions.

Provider Credentials

The credentials and specialization of the treating provider can affect pricing. Clinics staffed by board-certified psychiatrists or anesthesiologists may charge more than those staffed primarily by nurse practitioners or physician assistants, reflecting differences in overhead, training, and liability.

Treatment Frequency

The total cost of ketamine therapy depends heavily on individual response and maintenance requirements. Some patients achieve sustained remission after an initial series and require only occasional booster sessions, while others need more frequent ongoing treatment. The annual cost can vary by a factor of three or more based on individual maintenance needs.

Hidden and Additional Costs

Beyond the direct cost of ketamine treatment, patients should consider:

  • Transportation — In-clinic treatments require travel, and patients cannot drive after sessions. Ride-share costs, parking, or the time of a companion who provides transportation should be factored in.
  • Time away from work — Each in-clinic session requires several hours, including travel, treatment, and recovery time. For patients who must take time off work, lost wages represent an indirect cost.
  • Concurrent therapy — Psychotherapy, which is recommended alongside ketamine treatment, adds its own cost. Ketamine-assisted psychotherapy (KAP) integrates therapeutic support directly into treatment sessions. Many insurance plans cover psychotherapy, but copays and out-of-pocket limits apply.
  • Lab work and screening — Some providers require baseline laboratory testing, cardiac screening, or psychological assessment before initiating ketamine therapy.

Strategies for Managing Cost

Insurance Advocacy

For Spravato, obtaining insurance coverage often requires prior authorization and documentation of treatment-resistant depression. Working with the prescribing provider's office to submit thorough prior authorization requests — including documentation of failed medication trials and clinical severity — can improve the chances of approval.

Patient Assistance Programs

Janssen offers the Spravato Savings Program for commercially insured patients, which may reduce out-of-pocket costs. Some ketamine clinics offer sliding-scale pricing, payment plans, or financial hardship programs.

Flexible Spending and Health Savings Accounts

Ketamine therapy — including IV infusions, IM injections, and prescribed compounded formulations — may be eligible for payment through Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs), as it is a prescribed medical treatment. Patients should verify eligibility with their plan administrator.

Comparing Options

Patients are encouraged to research multiple providers and treatment modalities before committing to a course of therapy. Factors to compare include per-session cost, the number of sessions in the initial protocol, estimated maintenance frequency, included services, and the provider's clinical experience with ketamine therapy.

The Cost-Effectiveness Perspective

While ketamine therapy represents a significant financial commitment, it should be evaluated in the context of the broader costs of treatment-resistant depression — including other medication trials, hospitalizations, emergency department visits, lost productivity, and diminished quality of life. For patients who have not responded to conventional treatments, the cost of continued suffering and dysfunction may exceed the cost of ketamine therapy. Health economic studies have begun to evaluate the cost-effectiveness of ketamine and esketamine, with some analyses suggesting favorable cost-effectiveness ratios for treatment-resistant populations. For the latest on insurance developments, see our article on insurance coverage trends in 2025.

Note: This article is for educational purposes only and does not constitute financial or medical advice. For more on costs, see how much ketamine costs. Costs cited are approximate and subject to change. Patients should contact specific providers and their insurance companies for current pricing and coverage information.

References

  • MedlinePlus: Esketamine Nasal Spray — National Library of Medicine drug information on Spravato, including administration requirements that affect cost
  • StatPearls: Ketamine — Clinical reference covering ketamine administration routes and dosing that influence treatment costs
  • FDA: Drug Information — FDA resource on approved drug products including Spravato pricing and REMS program requirements
  • NIMH: Depression — National Institute of Mental Health information on depression treatment options and access

Share

Share on X
Share on LinkedIn
Share on Facebook
Send via Email
Copy URL

Patient Journey Guides

Explore our step-by-step guides to ketamine therapy, from your first appointment through long-term maintenance.

Browse guides